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The  uterus,  stimulated  continually  by  hormones,  denuded 
monthly  of  its  endometrial  mucosa,  and  inhabited  periodically  by 
fetuses is subject to a variety of disorders. One among them is fibroid 
(leiomyoma) uterus, which is the benign smooth muscle tumour of the 
uterus and it is the most common of all uterine neoplasms. It seems that 
myoma are dependent on estrogen for continued growth, it is possible 
that  estrogen is also a factor  in endometrial  changes.  Thus one must 
anticipate the association of these two. So especially interesting is the 
condition of the endometrium in association with fibroid. It may show 
little or no departure from the normal and the histologic sequence of 
cyclic change may occur just as it does in the ovulatory cycle of non 
myomatous patients.  On the other hand in a considerable proportion of 
case one finds an association of the non ovulatory type of cycle with 
myoma with frequently hyperplasia of the endometrium of more or less 
marked  degree.  This  dissertation  deals  with  the  study  of  changes  in 
endometrium associated with leiomyoma uterus with special reference 
to  submucous,  intramural  and  subserous  fibroid  in  all  Hysterectomy 
specimens  from  Govt.  RSRM  hospital  and  those  are  available  in 
department  of  pathology,  Stanley  Medical  College,  Chennai  for  the 
period of August 2003 to February 2006.
AIMS AND OBJECTIVES
1. To  analyze  the  incidence  of  leiomyoma  in  hysterectomy 
specimens.
2. To analyze the site wise distribution of leiomyoma in uterus.
3. To  analyze  the  histomorphological  pattern  of  endometrium  in 
leiomyoma uterus.
4. To study the endometrial changes in fibroid uterus on the basis of 
different age group.
5. To analyze associated changes in myometrium.
6. To analyze the endometrial changes in relation with LMP.
REVIEW OF LITERATURE
EMBRYOLOGY AND HISTOGENESIS
The genito urinary system develops from the urogenital ridge by 
21st day  after  fertilization;  the  end  term  of  the  embryo  forms  the 
primitive gut, which is attached by a mesentery to the posterior wall of 
the body cavity. The posterior wall on either side of the mesentery is 
made up of intraembryonic mesoderm. From the lateral side of this inter 
mediate cell  mass develops the urogenital ridge mullerian ducts form 
most of the female genital tract on the mesonephros from invagination 
of coelom epithelium. By the 8th week they grow caudally and cross 
entering to the wolffian duct and the gubernaculums, to fuse in the mid 
line and end at the roof of the urogenital sinus, forming an elevation 
called  mullerian  tubercle.  On  each  side  the  cranial  longitudinal  part 
forms uterine tube and its coelomic opening develops the fimbrial end. 
The intermediate unfused part of duct expands and finally fuse to form 
the uterus as fundus and the body.
ANATOMY
The uterus of an adult weighs on average from 30 to 50 grams. The 
measurements are subject to individual variations. It’s average length 
range from 5-7 cm. its greatest depth is 3 cms. The body of uterus 
comprises of an anterior and a posterior wall, fundus and the lateral 
margins. It contains a narrow triangular space called the endometrial 
cavity. The base of the triangle is the interior limit of the fundus, 
while the angle lies at the internal os of the cervix. The endometrial 
cavity communicates with the fallopian tube through the right and 
left cornua. 
APPLIED HISTOLOGY
The  histologic  architecture  of  the  body  of  the  uterus  in 
characterized by 3 layers
1. Serosa - Outer layer 
2. Myometrium - Middle layer    
3. Endometrium - Inner layer
The serosa is identical with the peritoneum
The myometrium is composed of fibres that are arranged 
interlacing bundles between the strands of interstitial connective tissue. 
Endometrium consists of endometrial glands and stroma and 
characteristic changes takeplace in the endometrium during different 
stages of menstrual cycle.
HISTOLOGY OF ENDOMETRIUM
Endometrium composed of two layers. They are stratum 
basalis, the basal thin layer and stratum functionalis, the superficial 
thick layer. This layers formed by glands, held together by connective 
tissue called as endometrial stroma and lined on the surface by simple 
columnar epithelium. The stroma consists of embryonic type, highly 
cellular connective tissue containing blood vessels and nerves. The two 
layers of endometrium are distinguished by the arrangement of blood 
vessels. The stratum functionalis is shed during menstruation and 
stratum basalis is permanent. The arteries from the arcuate -> radial -> 
straight artery enter into the basal layer then as they progress more 
apically they becomes tortuous finally giving off numerous branches. 
The capillaries end in capillary bed that includes lacunae – thin walled 
dilated segments at the superficial portion of stratum functionalis. (Ross 
et al, 1995) The surface epithelium is less responsive to hormonal 
stimuli. The functionalis layer is more responsive to hormonal stimuli. 
The basal layer does not respond to hormonal stimuli.
THE GLANDULAR EPITHELIUM
The  glandular  epithelium  is  a  single  layer  of  columnar 
epithelial cells. Their height varies depending upon the functional state, 
from 6µ postmenstrual to 20µ at the end of proliferative phase. During 
the proliferative phase  the nuclei  of  glandular  cells  are  enlarged and 
have a dense chromatin. Between the 10th and 16th day of the cycle their 
DNA content reaches its maximum (Voker, 1951). During the secretory 
phase the nuclei becomes round, vesicular. The nuclei contain abundant 
RNA. The RNA of cytoplasm reaches its  greatest  concentration after 
ovulation. The nucleoli of early proliferative phase are finely granular 
and compact.  They enlarge as midcycle is approached and may reach 
2.8µ in  diameter  (Fassake  et  al,  1965).  During the first  week of  the 
secretory  phase  the  nucleoli  contains  a  characteristic  tubular  or 
meshwork  like  structure,  the  nucleolar  channel  system  which  is 
embedded in an electron dense matrix and contains RNA. It serves the 
exchange  of  protein  between  nucleolus  and  cytoplasm  for  enzyme 
synthesis (Dubauszky and Pohlmann, 1960, Armstrong et al, 1973). The 
channel  system  apparently  occurs  only  in  human  endometrium  and 
seems  to  depend  on  adequate  levels  of  progesterone.  It  can  be 
demonstrated  shortly  before  ovulation  by  Electron  microscopy 
(Feldhaus et al, 1977).
During the proliferative phase the cytoplasm is unusually rich in 
RNA as disclosed by histochemical techniques (Wislocki and Dempsey, 
1945)  or  by  fluorescence  microscopy  (Dallenbach  and  Dallenbach  – 
Hellweg,  1968).  The  cytoplasm especially  the  basal  part  of  the  cell 
contains  abundant  ribosomes  (Borell  et  al,  1959)  Bundles  of 
tonofilaments each about 100µ diameter appear around the 13th day of 
the  menstrual  cycle,  under  the  influence  of  increased  estrogen 
stimulation, and they are stabilizing the rigidity of cells prior to nidation 
(Clyman et al, 1982). At the base of the cell near the first aggregate of 
glycogen  the  mitochondria  multiply  and  enlarge  with  the  onset  of 
secretory phase. Abundant basal secretory granules then collect around 
smooth endoplasmic reticulum. As glycogen, mucopolysaccharides and 
proteins accumulate at the lower pole of the nucleus to form cloudy or 
granular deposits, the large mitochondria nearby swell to giant size and 
may  reach  7µ in  diameter.  On  the  17th day  of  the  menstrual  cycle 
glycogen is found scattered throughout the cytoplasm, with the onset of 
secretion on 19th and 20th days the cytoplasm along the luminal surface 
sends  out  enlarged  microvilli  filled  with  secretory  products.  Shortly 
thereafter  the apical  portion of  the cell  is  discharged into the lumen. 
Thus,  the  epithelial  cell  expels  their  products  by  apocrine  secretion 
thereby  becomes  smaller.  The  glycogen  thought  to  serve  a  complex 
function involving more than pure glandular secretion (Sakuma, 1970).
Occasionally ciliated columnar cells found among the glandular 
epithelial cell (Mandl, 1911). The ciliated cells initially lie against the 
basement membrane and because of their abundant translucent 
cytoplasm can be readily recognized as a “clear cell”. Their rounded 
nucleus is generally located above those of the neighboring epithelial 
cells (Feyrter and Froewis, 1949) ‘clear cells’ are possible precursor 
cells in the proliferative phase and in glandular cystic hyperplasia. Fully 
developed ciliated cells are most numerous around midcycle and in 
hyperplasia of endometrium (Maddi and Papanicolaou, 1961).
THE SURFACE EPITHELIUM
During the proliferative phase the superficial epithelium closely 
resembles the glandular epithelium although it contains greater number 
of ciliated cells (Ferenczy et al, 1972). Glycogen appears earlier, in 
large amounts and remains longer than it does in the glandular 
epithelium. The superficial epithelium differs from glandular epithelium 
functionally. Its secretion is important for the adherence and 
implantation of blastocyst. As revealed by Scanning Electron 
Microscopy, the ciliated cells accumulated around the mouths of the 
glands (Hafez et al, 1975). During the secretory phase the cilia 
degenerate and as the apical surface of the cell continues to bulge into 
the uterine cavity, the size and number of its microvilli decrease 
(Johannission and Nilsson, 1972).
THE STROMAL CELLS
The endometrial stroma consist of pluripotential mesenchymal 
cells, which at the beginning of the menstrual cycle are uniformly 
spindle shaped, poorly differentiated, and joined to one another by 
cytoplasmic processes. The cell lie firmly anchored within a delicate 
network of reticulin fibers. Their elongated nuclei have abundant 
chromatin. At the beginning of the menstrual cycle the cytoplasm of the 
cells forms a narrow rim around the dark nuclei. Near the end of the 
proliferative phase the nuclear substance becomes less dense, the 
nucleoli grow larger and more conspicuous, and the nuclear membrane 
becomes wrinkled. The RNA accumulates in the cytoplasm of the more 
superficial stromal cells, and their smooth and rough endoplasmic 
reticulum expand. The Golgi apparatus and mitochondria remains 
poorly developed. Microfibrils of collagen become apparent, not only 
within the cell but also outside of them (Wetzstein and Wagner, 1960).
During  the  secretory  phase  the  mitochondria  and  smooth 
endoplasmic  reticulum  increase  in  number  and  the  Golgi  apparatus 
enlarges. Vacuoles and granules begin to appear in the expanding but 
shortened microvilli. From the 20th day of the cycle onwards, glycogen 
and glycoproteins in diffuse and granular form can be demonstrated in 
the  cytoplasm  of  the  stromal  cells  with  Electron  Microscopic  and 
histochemical methods (Mckay et al, 1956). Some stromal cell contains 
fine  lipid  droplets  (Aschheim  1915)  which,  appears  after  estrogen 
stimulation. When the lipid accumulates in large amounts the stromal 
cell  may  reach  the  size  of  decidual  cells  and  acquires  a  foamy 
cytoplasm.
Towards the end of the secretory phase there is accumulation of 
endometrial granulocytes. These cells are smaller than decidual cells 
have a crenated nucleus (Nordquist, 1970) and contains relatively large 
lysosomal granules (Hamperl, 1954, Hellweg, 1954), originally thought 
to be derived from stromal cells (Dallenbach – Hellweg, 1981) and to 
secrete a protelytic hormone – relaxin (Dallenbach & Dallenbach – 
Hellweg, 1964), it has now been shown that the endometrial 
granulocytes are, a population of large granular lymphocytes, probably 
derived from bone marrow, which have natural killer (NK) 
characteristics (Bulmer et al, 1987). They play a role in successful 
implantation and placentation (Ritson and Blumer, 1987). These cells 
contain phloxinophilic granules in the cytoplasm (Hamperl, 1954, 
Hellweg, 1954). These cells also called as stromal granulocytes or 
endometrial granulated lymphocytes. They expresses CD59 & CD69 
postivity.  
OTHER CELLS IN ENDOMETRIUM
Lymphocytes appears frequently in non – inflamed endometrium. 
Lymphoid follicle in endometrium not unusual (Monch, 1918). 
Histiocytes and mast cells also found in the endometrium. Plasma cells 
and eosinophils appears very rarely (Feyrter, 1957).
THE RETICULIN FIBERS
The reticulin fibers distribution varies in the endometrium. The 
stroma of the basalis and the isthimic mucosa remains uniformly dense. 
The  fiber  content  of  the  functionalis  layer  fluctuates  during  the 
menstrual cycle (Hormann, 1908, Hoffmeister and Schulz, 1961). With 
the light microscopy only occasional delicate reticulin fibers seen during 
the first 8 days of the proliferative phase. As ovulation approaches, these 
fibers become denser and thicker. By the 4th week of the cycle, the fibers 
enmesh  each  predecidual  cell  and form a  dense  network  around  the 
glands and the spiral arterioles. Later when progesterone decreases, the 
reticulin fiber disintegrates. As a result the glands separate from stroma 
and stromal cell dissociate from one another. From the appearance and 
quality of reticulum network the functional state of endometrium can be 
evaluated (Vaczy and Scipiades, 1949).
THE GROUND SUBSTANCE
The ground substance of the endometrium bathes the cellular and 
fibrous components of endometrium. In the early and mid proliferative 
phase  it  chiefly  contains  high  molecular  neutral  and  acid 
mucopolysaccharides.  In  the  late  proliferative  phase  the  ground 
substance begin to resolve into subgroups of low molecular size. As the 
time for implantation approaches in the midsecretory phase it becomes 
oedematous. During 4th week of menstrual cycle high molecular, neutral 
and  acid  mucopolysaccharides  reaccumulate,  in  the  compacta  and 
around the spiral arteriole. These changes are necessary for implantation 
of blastocyst.
THE VESSELS
The vessels of the stratum functionalis differ from vessels of other 
organ and tissues by their unique structure, their sensitivity to hormones 
and their ability to respond quickly to such stimuli (Ramsey, 1955, 
Nieminen, 1962). In contrast, the vessels of stratum basalis are 
influenced little by hormonal changes of the cycle. The spiral arterioles 
of the functionalis that branch from the arteries of the basalis finally 
attain the upper portion of the endometrium at the end of proliferative 
phase. Progesterone stimulates the vessels to grow larger and longer, 
hence leading in their tortuosity. Such changes are especially evident 
during the second half of the secretory phase when the ratio of the 
height of endometrium to the length of the spiral arteries is 1:15 
(Markee, 1950). The arteries undergo intense spiraling because they 
grow faster than the endometrium. Their wall, thin in the early 
proliferative phase grows progressively thicker (Wiegand, 1930, Farrer 
– Brown et al, 1970). The lining endothelial cells, originally flat, swells 
and soon contain large, vesicular nuclei (Keller, 1911). The capillaries 
of the functionalis also respond to cyclic variation of the ovarian 
hormones. They branch and pass just beneath superficial epithelium, 
there it become largest in premenstrual phase and in decidua of 
pregnancy. They form lacuna like sinusoids called as anastomosing 
lacuna of Schmidt - Matthiesen (Schmidt – Matthiesen, 1962).
The veins of stratum functionalis respond to the hormonal stimuli 
of secretory phase, as other vessels (Küstermann, 1930). The venous 
network of the endometrium is strikingly dense. They form thin walled 
“lakes” beneath the superficial epithelium.
PHYSIOLOGICAL  ACTION  OF  HORMONES  ON 
ENDOMETRIUM
Though Andreas Vesalius in 1545 known about the pituitary and 
hypothalamus relationship only in 1947 Green and Harris recognized it 
as a neurovascular complex. The gonadotrophin hormones discovered 
by Ascheim and Zondek in 1927. Fevold, Hisaw and Leonard described 
the FSH and LH in 1931. But the normal sequence of events in 
menstrual cycle in relation to pituitary and ovary was described only in 
1971 by Speroff and Van de wiele, and Newton et al. Later in 1973 
Fraser et al found irregular menstrual cycles are due to FSH & LH 
deficiency.
HORMONAL CONTROL OF OVULATION
Ovulation depends upon complex interrelationship of 
hypothalamus, pituitary and ovary. The gonadoprophin releasing 
hormones (FSH / LH – RH) carried in the hypophyseal vessels to the 
anterior pituitary, stimulates the synthesis and release of FSH and LH 
into general circulation. These hormones are necessary for follicular 
growth and maturation in the ovary.
At  about  midcycle  there  is  an  additional  surge  of  LH release 
which  causes  the  FSH  primed  follicle  to  rupture  and  discharge  the 
ovum. The ruptured follicle is then transformed into a corpus luteum 
HYPOTHALAMUS
which synthesize progesterone and estrogen. These steroid hormones of 
ovary  inhibit  the  ovarian  stimulation  by  gonadotrophin  by  negative 
feedback in Hypothalamo – pituitary axis. If fertilization does not occur, 
the  corpus  luteum  remains  transient;  involutes;  ovarian  hormone 
decreases  in  quantity  and  menstruation  follows.  The  hypophysis 
resumes their function and the cycle repeats itself.
   Hormonal levels in normal menstrual cycle
ENDOMETRIAL STEROID RECEPTORS
The steroid hormones though diffuse into all cells; they trigger their 
activity through specific receptor sites on the target cells. From the 
receptor they are carried to the nucleus and to genes to induce 
transcription and translation resulting in cell proliferation and 
differentiation (Gorski and Gannon, 1976).
In the stratum functionalis, the receptors for estrogen and 
progesterone fluctuate during the menstrual cycle (Bayard et al, 1978). 
The estrogen receptor when unoccupied by estrogen in the nucleus 
loosely bound in the monomer state. With estrogen binding, activation 
involves the formation of dimer (Scholls, 1984). One aspects of 
activation is an increased affinity for estrogen. Increase in affinity is 
called positive cooperativity, which increases the receptor’s ability to 
respond small changes in the concentration of hormone. The mechanism 
of action is same with progesterone (Edwards et al, 1969). The 
concentration of estrogen and progesterone receptors is higher in the 
fundal region than in the middle and isthimic portion of the uterus 
(Kauppila et al, 1982). The basalis layer shows constant receptor 
number and binding is independent of the cycle phase. 
The hormonal effect on epithelial, stromal and endothelial cells is 
mediated by estrogen receptor (E2 R) and progesterone receptor (PR) 
(Katzenellenbogen, 1980), also the regulation of EGF receptor content is 
achieved by ovarian hormone secretion (Ferenczy, 1994). The receptors 
synthesised in the cytoplasm transported into the nucleus by a dimer of 
heat shock protein (hsp – 90). With the formation of hormone receptor 
complex hsp – 90 dissociates. In the early proliferative phase, estradiol 
receptors  gradually  increase.  The  progesterone  receptors  are  slightly 
fewer than estrogen receptor.
In the late proliferative phase the concentration of total estradiol 
receptors increases. The cytoplasmic receptors increase greatly, 
correlating with the surge of plasma estadiol. After ovulation the total 
estradiol receptor decreases rapidly in the early secretory phase. 
ESTROGEN
In contrast to other steroid hormones minute amount of estrogen 
are very potent, capable of producing rapid and significant changes in 
the target cell. In endometrium both stromal and glandular cell responds 
briskly to the estrogen. Estrogen regulates the amount of genetic 
material available for transcriptional results in cell proliferation seen as 
mitosis. The first change in the glandular and stromal cell of 
endometrium is the increase in RNA in the nuclei and nucleoli, followed 
by increase in the cytoplasmic RNA (Davidson, 1965). Finally with the 
secretion of progesterone, the endometrial cells cease to proliferate.
PROGESTERONE
In  the  human  endometrium  the  first  evidence  of  progesterone 
effect  is  detectable  with  the  light  microscope  after  36  hours.  The 
changes  are  clearing  of  the  nuclei  of  glandular  epithelial  cells  and 
appearance of glycogen granules at the base of the glandular epithelial 
cells.  In  Electron  Microscopic  studies,  giant  mitochondria  containing 
DNA  near  the  glycogen  granules  found  (Merker  et  al,  1968).  The 
progesterone stimulates the mitochondria to synthesize protein. Later in 
the  menstrual  cycle  under  the  influence  of  progesterone,  a  nuclear 
channel  system develops.  Mitotic  activity  ceases.  The  glandular  cell 
produces glycogen, neutral and acid mucoploysaccharides and lipids. In 
the 2nd week of the secretory phase the stromal cells differentiate into 
large predecidual cell.
THE NORMAL MENSTRUAL CYCLE
The first histological description of the cyclic changes of the 
endometrium was done by Hitschmann and Adler (1908).
However, Noyes et al in 1950, first described in detail on how “to 
date endometrium” from histologic criteria, that is on how to diagnose 
how far  an endometrium has developed in the menstrual  cycle, from 
characteristic histological changes that are known to occur at specific 
times. Moricard in 1954 and Philippe et al in 1965 confirmed the data of 
Noyes et al.
The menstrual cycle divided into three phases :
1. Proliferative phase
2. Secretory phase and
3. Menstrual phase
PROLIFERATIVE PHASE
The endometrium regenerates from the basal layer and that part of 
the functional layer, which remains after menstruation. The epithelium 
rapidly covers over the denuded surface. Mitotic activity is not much in 
evidence in the early stages of regeneration. The initial resurfacing 
occurs independently of hormonal stimulus. The normal proliferation 
lasts about two weeks. But the time taken for the development of follicle 
varies from women to women and between cycle to cycle. It is therefore 
impossible to date the proliferative phase with any accuracy and it is 
divided into early, mid and late proliferative phase. In the early stages 
the glands have a low columnar epithelial lining measuring 6µ in height 
and a simple tubular appearance. There is evidence of mitotic activity 
both in the glands and in the stroma. The stroma composed of spindle 
cells and somewhat loosely packed.
In the mid proliferative phase the glands continue to elongate and 
the stromal edema develop. The elongation of the glands outstrips the 
stromal edema and consequently the glands become tortuous in 
appearance. In the late proliferative phase the stromal edema subsides 
and the tortuosity of the glands further increases. The mitotic activity is 
maximum in the glands and stroma, corresponding with the preovulation 
peak of the estrogen. The glandular epithelium shows pseudostratified 
appearance due to heaping up of the columnar epithelium. The glandular 
cells measure 20µ in height. The lumen appears distended. Small 
amount of glycogen vacuole is found in the cells. Nucleoli in the 
glandular cells become more prominent as the proliferative phase 
progresses. The individual stromal cells show little change over the 
period other than growth and appear to contain little cytoplasm in H & E 
sections (naked nuclei appearance). The cell remains well anchored in 
the reticulin network.
SECRETORY PHASE   
Secretory phase is divided in to three phases
1. Early secretory phase
2. Mid secretory phase and
3. Late secretory phase
In  the  glandular  epithelium subnuclear  vacuoles  occur  after  36  –  48 
hours after ovulation. It is regarded as one of the early sign of ovulation, 
when the majority of the cells show vacuolation. During 16 -19 day of 
cycle the secretory material of the subnuclear vacuole gradually moves 
to the apical pole of the cell and nuclei takes up a basal position. By the 
16th day of cycle the glands have lost their pseudostratification. Mitotic 
activity is still apparent and continues in the glands for some 2 – 3 days 
after  ovulation  and  slightly  longer  in  the  stroma.  The  progesterone 
secretion makes the cell  to lose their ability to divide.  So,  mitosis  is 
absent after 19th day.  During ovulation the epithelial cell expresses B72 
and 32 very late antigens – 1. (Ferenczy, 1994)
The secretory material accumulates at the apical poles of the cells 
and protrudes as blunt projections into the gland lumen, becoming 
maximal by day 21 of the cycle. As the material is shed by the apocrine 
method, the epithelial surface assumes a more irregular shaggy 
appearance and secretory material dilates the gland lumens. Secretory 
activity continue for several days after ovulation and then, if pregnancy 
does not ensue, decline after day 22. The pattern of secretory activity 
varies in different part of endometrium. The glands begin to show 
involutional changes and there is inspissation or gradual disappearance 
of luminal secretion. The glands progressively collapse and papillary 
tufts of epithelium project into the lumen, giving the characteristic saw 
toothed appearance. 
There after the gland show variety of degenerative changes with 
ragged epithelial cell borders and the appearance of apoptosis and giant 
autophagocytic  lysosomes.  During  the  second  half  of  the  secretory 
phase the stroma shows typical changes. If pregnancy has not ensued, 
the  corpus  luteum  begins  to  involute  and  there  is  fall  in  plasma 
progesterone levels.  The estrogen levels which show a temporary fall 
after ovulation, reach a second peak by day 21 and 22. Stromal oedema 
begins  apparent  during  this  time  of  maximal  estrogen  stimulation. 
Increased level of estrogen associated with vascular endothelial swelling 
and  increased  fenestration  of  the  endothelial  capillary  lining.  These 
changes are mediated by prostaglandin F2 (PGF2) and prostaglandin E2. 
(Ferenczy, 1980, Smith et al, 1983). 
The  edema  subsides  by  23rd day.  The  spiral  arteriole  becomes 
more prominent. This is due to increase in length of the arterioles and in 
part  to  the  predecidual  changes  which  occurs  in  the  stromal  cell 
immediately adjacent to these vessels.   The stromal cells enlarge and 
assume a polygonal shape with small rounded nuclei; the cytoplasm is 
copious  and  shows  the  accumulation  of  glycogen  and  lipid.  These 
changes allow the separation of the endometrim.  During the last  two 
days of the cycle prior to menstruation the stroma shows accumulation 
of endometrial granulocytes. 
MENSTRUATION 
At the end of each cycle if pregnancy has not occurred a 
proportion of the endometrial lining is shed. This together with blood 
inspissated secretory products and other debris makes up the menstrual 
flow. Usually lasting for some four days, the process is related to 
hormonal levels. Both estrogen and progesterone become deficit in the 
later stage of the cycle (Zuckerman, 1949). The hormones also cause 
loss of fluid in endometrium and it shrinks (Markee, 1950), 
approximately 30% of the bulk being lost. This shrinkage results in 
further coiling of the spiral arteriole with further reduction in blood 
flow. The shrinkage causes the glands to pack more closely together and 
gives an impression of increased cellularity which is heightened by the 
endometrial granulocytes and leucocytes accumulating at this stage. In 
the few days immediately preceding the menstruation there is 
constriction of the spiral arteriole brought about by shrinkage of 
endometrium with blanching of the overlying epithelium. It has been 
suggested that the triggering effect on spiral arteriole is due to a 
reduction in the circulating progesterone-estrogen concentration below 
some critical level (Zuckerman, 1949 loc cit). After a time the vessels 
dilates and the damaged vessel wall allows the red blood cells to pass 
through. As a result small haematoma collect beneath the surface, 
raising blebs. When the necrotic epithelium is shed the blood comes to 
lie directly on the surface. The shedding of endometrium starts 
superficially and proceeds to the deeper layer and rapid disintegration 
then takes place. The endometrium usually shed in piecemeal fashion 
and occasionally shed in larger fragments. The tissue is heavily 
infiltrated by acute inflammatory cells. 
THE MENSTRUAL CYCLE VARIATION 
The variation in cycle length in different women is considerable, 
the mean is 29.6 days. There is a tendency for mean cycle length to 
decrease with age from 30.1 days at the age 20 – 27.2 days at the age 40 
(Treloar et al, 1967). Any menstruation outside this limit, any bleeding 
at other times in the menstrual cycle and any acyclical, premenopausal 
bleeding are considered as abnormal. The duration of menstrual 
bleeding also varies in different women from 2 to 7 days with a mean of 
5 days (Guillebaud and Bonnar, 1978), but any menstruation lasting 8 
days or longer should be regarded as excessive. The average menstrual 
blood loss is about 80ml per cycle (Hallberg et al, 1966) and blood loss 
more than that considered abnormal. 
DYSFUNCTIONAL UTERINE BLEEDING
The endometrium responds to every alteration in hormonal 
balance that occurs as a result of absence of hormone, deficiency of 
hormone, or excessive secretion of hormone. Alteration in the hormone 
status either due to primary-intrinsic ovarian abnormalities or 
secondary-disturbances in the hypothalamo- pituitary–ovarian axis such 
hormonal changes produce arrest in follicular maturation at different 
stagers of its development and results in morphological changes that 
corresponds to the stage of maturation at which the follicle become 
impaired. Follicular arrest will lead to lack of endometrial stimulation, 
when the injury occurs during the hormone secreting stages of follicle or 
corpus luteum. When the injury results in arrest of follicular regression 
with anovulation or prevents involution of the corpus luteum the effect 
on the endometrium will be that of hyper stimulation.
Hormonal imbalance may be due to deficiency of one hormone or 
normal state of one and excessive amount of other. This imbalance 
induces morphological changes in the endometrium. These 
morphological changes can be differentiated with additional factors like 
history and general examination of patient and the diagnosis can be 
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During the reproductive year endometrial atrophy is always 
abnormal, and indicates a complete lack of endometrial response to 
ovarian hormones. This may be caused by primary absence or 
surgical resection of ovaries or their functional eradication by 
radiotherapy or chemical toxins, by severe damage to the controlling 
pituitary hypothalamic centre or by local refractoriness of the 
endometrium to the ovarian hormones. The endometrial 
refractoriness associated with normal ovarian function and a regular 
biphasic menstrual cycle (Plotz, 1950; Eufinger 1952), is termed as 
the ‘silent ovulation’ of Stieve (1952). This condition is due to an 
inability of the endometrial cells to produce hormone receptors. 
Cellular proliferation and differentiation cannot takes place if either 
the hormone or the receptor is not available. 
Histologically, the epithelial and stromal cells are small even at 
higher magnification. Glands can hardly be distinguished under low 
magnification or at best resembles capillaries. They are small very 
sparse and lined by low cuboidal epithelial cell having small, round 
nuclei with dense chromatin. The cytoplasm is scanty, and mitosis is 
lacking. The stroma consists of small, densely packed spindle cells. 
The entire height of endometrium is very much reduced and the 
stratum basalis cannot be recognized. In extreme instances no glands 
remain and the flat epithelium of the surface is separated from the 
myometrium by a stromal layer just a few cell thick. The blood 
supply is minimal and no spiral arterioles can be made out. The 
atrophy of the endometrium is sometimes associated with the 
development of large dilated venules situated superficially under a 
thin endometruim. These venules may rupture and are probably the 
cause of uterine bleeding. 
DEFICIENT PROLIFERATION 
If a growing follicle, does not reach maturity because of central 
hypogonadotrophism or ovarian damage and remains functionally 
insufficient, too little estrogen will be produced with two consequences. 
1. The LH peak will  not develop and LH levels will  remain low 
because  of  insufficient  feed  back  stimulation,  due  to  the 
diminished  concentration  of  FSH  in  the  early  phase.  Thus 
ovulation dos not take place. 
2. The  endometrium  will  not  proliferate  correctly,  because  it  is 
under stimulated. Although the LH concentration is too low to 
induce  ovulation  it  may  cause  sporadic  luteinizaltion  in  the 
sufficient follicle. 
Histologically, the endometrial glands and stroma show a distinct 
retardation of growth. The glands remain narrow and straight. Their 
lining epithelium is low columnar and contains chromatin rich nuclei 
in single rows with scanty cytoplasm. The estrogen receptor content 
is low. Mitosis is rare. The stromal cells are small, spindle shaped, 
poorly differentiated and densely packed. The general height of the 
endometrium is moderate, with its surface slightly irregular because 
of variations in growth. The regions close to the blood supply are 
slightly more advanced in their proliferation than the neighboring 
more peripheral regions. This picture remains consistent throughout 
the menstrual cycle with little variation. Occasional basal vacuoles 
may found, indicates focal abortive secretion induced by little 
amount of progesterone produced in luteinized regions of the
 insufficient follicle. 
IRREGULAR PROLIFERATION:
Although a follicle has normally matured, ovulation may not take 
place, either because of a central defect in LH stimulation or 
hyperstimulation with FSH, or because of an ovarian damage. The 
unruptured (Persistent) follicle will continue to produce estrogen beyond 
the proliferation phase for a varying number of days and will then 
slowly regress, resulting in anovulatory shedding which may occur at 
the same time as menstrual shedding, or may be more or less delayed, 
depending upon how long the follicle persist. Irregular proliferation may 
also develop when previous repeated anovulatory cycles have built up a 
relative estrogen predominance, which increases with each successive 
anovulatory cycle. 
Histologically, the growth of the glands and stroma clearly 
exceeds that of the normal proliferative phase. The glands vary in their 
distribution, lying either closely packed or widely dispersed, and their 
diameters differ considerably. Some may be lined by a pseudostratified 
or even stratified tall columnar epithelium. On immunohistochemical 
examination the nuclei of proliferating epithelial cell show strong 
positivity for estrogen receptors. The stroma is composed of densely 
arranged spindle cells and irregularly edematous. The spiral arteriole 
remains underdeveloped: instead thin walled venules are found. 
Although the height of the endometrium varies considerably, it is 
usually increased, often markedly so.
If the ovulation takes place rarely, the basal vacuoles seen in the 
highly proliferating glands, which are close to the blood supply. In these 
cases a delayed and deficient secretion had occurred that never 
developed as fully as in a normal menstrual cycle. In instance sporadic 
luteinization may occur in part of the granulosa cells of the persistent 
follicle in a similar manner as in the insufficient follicle. These 
luteinized cells may also produce small amounts of progesterone, which 
can induce abortive secretion with small basal vacuoles developing in 
the glandular epithelium. These can be differentiated from those of a 
truly delayed ovulation by their small size and scanty number. If an 
unopposed stimulation of estrogen persist then the irregular 
proliferation, gradually progress to a simple (Cystic) glandular 
hyperplasia or to atypical hyperplasia. 
OVULATORY DISTURBANCES 
THE DEFICIENT SECRETORY PHASE  
This entity encompasses a variety of disturbances in corpus 
luteum function of central or ovarian origin with or without preceding 
abnormal follicular development. Some of these syndromes can be 
precisely recognized morphologically as they specifically produce 
changes in the endometrial structure. 
The stimulatory effect of progesterone on the endometrium 
becomes deficient when the hormonal balance shift in favour of 
estrogen the progesterone deficiency can be absolute when the 
production or secretion of progesterone is suppressed or relative when 
hyperestrogenism develops. An absolute progesterone deficiency may 
occur after normal ovulation if the corpus luteum fails to develop 
normally or regress too quickly because of a central or ovarian defect 
such as inadequate lutenization of the granulosa cells or by suppression 
of progesterone release by elevated prolactin levels (Tubert, 1978) or an 
ovarian defect in the ability to induce follicular development (Fox & 
Buckley, 1982). 
A relative progesterone deficiency may follow a preceding 
follicular persistence with delayed ovulation. The associated secretory 
phase is of normal length or may show an early breakdown. In still other 
instances, the corpus luteum insufficiency is preceded by an impaired 
follicular development with inadequate stimulation of the granulosa 
cells which may be caused by insufficient FSH secretion in the early 
follicular phase. In these circumstances, progesterone cannot fully act on 
the deficiently proliferated endometrium. Furthermore the luteal phase is 
not only deficient but often also truly or apparently shortened (Strott et 
al, 1970, Jones, 1973 and 1975, and Sherman and Korenman, 1974). An 
apparently short luteal phase may result from early ovulation after short 
and deficient proliferation. On the other hand, the secretory phase may 
be either truly delayed after normal ovulation or apparently delayed 
following delayed ovulation. 
In most conditions the plasma progesterone concentration during 
the luteal phase are low (Moszkowski et al 1962, Abraham et al, 1974). 
In rare instance a defect of progesterone receptors in the endometrium 
may be the cause for a relative progesterone deficiency in the presence 
of a normally functioning corpus luteum (Laatikainen et al, 1983). 
Proper evaluation of the patient requires endometrial biopsy from at 
least two cycles (Jones et al, 1974). When applying strict criteria, a 
deficient secretory phase due to endogenous disturbances appears to be 
more common than previously assumed; although Israel in 1959 
reported it in only 3.5% of his infertile patient and Sillo – Seidle and 
Dallenbach – Hellweg in 1974 found 20% of their infertile patients. Just 
as the type and cause of disturbances or interference in the function of 
the corpus luteum may vary, so many of the histological findings. The 
deficient secretory phase is divided into two types, each with different 
cause (Gigon et al, 1970) 
PROGESTERONE RECEPTOR DEFICIENCY 
A deficient secretory phase is, found in women with a properly 
timed ovulation and a normally functioning corpus luteum (Laatikainen 
et al, 1983 loc cit and Spirtos et al, 1985). These patients have a local 
deficiency of progesterone receptors and, consequently, not only 
endogenous progesterone (Cooke et al, 1972), but also therapy with 
progesterone has no effect on the endometrium. 
ENDOMETRIAL HYPERPLASIA (STANLEY J. ROBBOY ET 
AL)
The endometrial hyperplasias are a heterogeneous group of 
proliferative disorders. A confusing multiplicity of descriptive terms 
and a variety of largely unsatisfactory classification hinders a full 
understanding of their nature.
The hallmark of hyperplasia is an increased amount of glandular 
tissue relative to stroma, with concomitant architectural and sometimes 
cytological changes. 
The International Society of Gynecological Pathologists (ISGP) and 
the World Health Organizatin (WHO) recently proposed a 
classification scheme in which architectural and cytological features 
are independently evaluated and this classification has now been 
widely accepted. This classification divides lesions into those that 
have cytological atypia and those that do not; the architectural 
pattern, which is simple or complex, is of secondary importance.








Endometrial hyperplasia is generally thought to result from 
excessive stimulation by estrogens. 
HITOLOGICAL FEATURES OF SIMPLE HYERPLASIA
General 
Diffuse changes throughout endometrium
Increased gland:stroma ratio (greater than 1:1)
Glands
Architectural features 
Variation in size and shape
Small to large and cystically dialated
Minimal and focal crowding
Minimal branching with infoldings and outpouchings
No complex angularity
Cellular features
Abundant and cellular epithelium










Small, oval cells with scanty cytoplasm
Mitotic activity in stroma
Prominent superficial venules
Inconspicuous spiral arterioles
HISTOLOGICAL FEATURES OF COMPLEX HYPERPLASIA
General
Focal to extensive
Greatly increased gland:stroma ratio (greater than 3:1)
Glands
Architectural features
Marked variation in size and shape
Marked crowding




Abundant and cellular epithelium












HISTOLOGICAL FEATURES OF SIMPLE ATYPICAL 
HYPERPLASIA
General 
Architectural changes diffuse throughout endometrium
Cellular changes focal to diffuse
Increased gland:stroma ratio (greater than 1:1)
Glands
Architectural features
Variation in size and shape
Small to large and cystically dilated
Minimal and focal crowding
Minimal branching with infoldings and outpouchings
No complex angularity
Cellular features
Abundant and cellular epithelium








Nucleoli prominent, enlarged and irregular





Small, oval cells with scanty cytoplasm
Mitotic activity in stroma
Prominent superficial venules
Inconspicuous spiral aeterioles
HISTOLOGICAL FEATURES OF COMPLEX ATYPICAL 
HYPERPLASIA
General
Focal to extensive 
Greatly increased gland:stroma ratio(greater than 3:1)
Glands
Architectural features
Marked variation in size and shape
Marked crowding
Branching with papillary infoldings and outpouchings
Complex angularity
Cellular features
Abundant and cellular epithelium









Nucleoli prominent, enlarged and irregular







Leiomyoma uterus are the most common tumours of  uterus and that 
of female pelvis. They are also the most common cause of 
hysterctomy world over (telinde et al). 52 percentage  autopsy 
studied have shown the approximately 20% woman over 30 harbor 
uterine myomas of various sizes (Novak et al)   
Leiomyomas are benign tumors composed mainly of smooth muscle 
cells but also varying amounts of fibrous tissue..
INCIDENCE
It’s impossible to determine the exact incidence of these tumors. 
They present i.e. 20-30% of women over 30 years of age, rising to 
more than 40% in those over 40 years old (malcomc. Aderson et al)
AGE
Leiomyomas occur chiefly in women during mid reproductive years. 
They have been reported on rare occasion in young girl 
(augensen-1818). Premenopausal patients showed an average number 
of myoma almost three times higher than post menopausal women 
(Cabreraj et al 1994)
RISK FACTORS
Age: as age at menarche decreases, there is an increased rise of two to 
threefold,  post  menopausal  women have  a  70-90% decreased  in  risk 
(Telinde et al)
Child  bearing:  Woman  who  has  a  live  born  child  have  a  20-50% 
decreases  in  risk.  This  reduction  in  risk  increases  with  number  of 
children  born.  However  the  protection  offered  by  child  birth  is  only 
temporary because the risk increases as time for her most recent child 
birth increases (Telinde et al)
Exogenous hormones:  Exogenous estrogen especially that unopposed 
with progestins show an increase in the risk (Telinle et al) 
Family history:  Positive family history increases the risk by upto 3.5 
fold (Telinle et al) 
Race:There is 9 fold increases in incidence of leomyoma among black 
woman (North American clinics)
Diet and other factors: Obesity increases the risk of developing fibroids, 
while cigaritte smoking is associated with reduced risk (Parassiini F et al 
1988). Myoma is associated with beef consumption where as high intake 
of green vegetable seems to have a protective effect (chiaffasino F etal 
1999).  Low physical activity, high mental stress were the risk factors in 
the etiology and pathogenesis of this disease (T.Katredry et al 1993)
ETIOLOGY
Uterine myoma was first believed to be a purely local growth, due 
to local reason but by the end of 19th century it became accepted that 
myoma  uterus  were  related  to  hormonal  disturbances.   In  1935 
Witherspoon  described  3  pathological  changes,  etiologically  closely 
related.
1. Myoma of Uterus.
2. Microcystic degeneration of ovary with incomplete leutinization.
3. Cystic glandular hyperplasia of the endomentrium (J clinic path 
1970). 
It is suspected that hormone especially estrogen, growth hormones 
and progesterone play a role in the development and maintenance of 
uterus leiomyoma. Faber et al  in 1972 and later Tamaya et al in 1978 
in their study found that the smooth muscle cells including those of 
levels are sometime increased in woman with leiomyoma. Muram et 
al in 1980 found that evidence of hormonal dependence includes the 
increased frequency of leiomyoma after menarche and growth of 
leiomyoma during pregnancy.
SITES OF OCCURRENCE
1. Uterine corpus (commonest)
2. Cervix
3. Broad ligament
4. Along other pelvis ligament.
5. Parasitic
6. Ovary (Tsalacopouls  H et al 1981)
with in the uterus tumors can be 
1. Intramural-75%
2. Subserous-10%
3. Submucous-15% (Shaw et al)
CLINICAL FEATURES (Telinde et al)
Abnormal menstruation
One  third  (30%)  of  patient  with  symptoms  present  with  menstrual 




4. Dysmenorrhoea or combination of these
PRESSURE SYMPTOMS
There is second most common way of presentation. These 
symptoms are due to the pressure effect of the leiomyoma on the 
surrounding structures. They may be in the form of frequency or 
difficulty in micturition, constipation, low back ache or pain or 
discomfort in the lower abdomen. Importantly 30% of the patients come 
to us with complaints of pain.
MASS ABDOMEN
A few of the patient may present with complaints of only mass 
abdomen.
REPRODUCTIVE FAILURE
It must be remembered that infertility or recurrent pregnancy loss 
when fibroids are the sole implicated cause but is rare (5%) 
Symptoms produced by leiomyomas are dependent on the location of 
the tumor with in uterus 
Location menstrual pain integrity bulk
Intracavitary     + + + -
Submucous      + + + -
Intramural      + + + -
Subserous      - + - +
Pedunculated      - + - +




(plexiform, leiomyoblastoma, clear cell)
Symplastic leiomyoma
Myxoid leiomyoma
Leiomyoma with hetero logous element 






Leiomyoma most frequently are solid and white they have a whorled 
appearance on cut surface. Ackerman et al in 1990 found that 84% of 
leiomyoma were multicentric.
MICROSCOPIC FEATURES (Robboy et al)
Leiomyoma is composed of interlacing fasicles of smooth muscle 
cells. The smooth muscle cells are markedly elongated and have 
eosinophilic cytoplasm and elongated cigar shaped muscle. In an 
uncompleted cases, it’s nuclei are uniform and mitotic figures absent 
or sparse. Abdundant reticulin is present.
DEGENERATIVE CHANGES
Punnonem in 1965 and Arjoon in 1970, in their studies found that 
most forms of degenerations are the result of replacement of muscle 
fibres by hyaline, collagen, blood, calcium, mucopolysaccharide or 
combination of these.
In 1964 Gupthaand hunter in their study found that cells admixed 
with smooth muscle cells in leiomyoma. Christopher et al in 1972 
reported cellular leiomyoma to be more common in older woman 
with uterine atrophy. In the same study they also reported on 
symplastic leiomyomas. These are benign smooth muscle tumor of 
uterus which conatin large bizarre cells with large nucles. Mitotic 
count is less than 2/10 Hpf. Willamson E.O and Christopherson in 
1972 reported that leiomyoma arising near serosa especially with 
pedicle may on rare occasions take up blood supply from the near by 
organs and detached them selves. These are called as parasitic 
leiomyomas
In 1977, Gasser and young in their studies reported neurilemmoma 
like leiomyoma. Leiomyoma some time resembles neurilemmoma 
due to stromal hyalinization. They usually demonstrate smooth 
muscle differentiation ultra strutually Mazur and Kraus in 1980 
reported tubular differentiation in otherwise characteristic 
leiomyoma. In 1991 Hu.John Surti et al found that cytogenetic 
alterations are common in uterine leiomyoma. The most common are 
rearrangements of 6p del7qt12 and t12 (12:14). 
Red degeneration of leiomyoma masquerating as retained products of 
conception. Mason tc etal 2002. The incidence of leiomyoma in 
pregnancy is approximately 1%. Their presence has been linked to 
spontaneous abortion, premature labor, soft tissue dystocia, uterine 
inertia, fetopelvic disproportion, malposition of fetus, retention of 
placentra and post partum haemorrhage.
Discovering of calcified uterine myomas is not frequent. Three case 
of uterine myoma reported as cause of pelvic classification and to 
establish differential diagnosis with bladder stones. Diagnosis is 
made by radiological studies in postmenopausal female patients 
(Hermida Perez et al 2003)
UTERINE PROLAPSE AND LEIOMYOMA 
In Mittak Y et al study 2004 investigated the frequency and 
implications of incidental findings in uteri removed for prolapse. 
They found a high frequency of incidental findings that was greater 
than previously reported.
ADENOMYOSIS
Adenomyosis of the uterus is a condition characterized by a benign 
invasion of the endometrium in to the uterine musculature, associated 
with diffuse overgrowth of uterus (Jeffcoat et al). Adenomyosis is 
found in 25 to 40 % of all hysterectomy specimens by bird and 
associates indicate that it sufficient sections are obtained ectopic 
endometrium may be noted nearly 62% uteri removed for all causes 
(Bird C et al 1972).
In adenomyosis the uterus may be slightly or markedly enlarged, 
though the increase in size never reaches the large proportions seen 
so often with myoma. However it must be remembered that 
adenomyosis and myoma often co exist, the myoma being 
responsible for the frequently large size of the uterus in such cases 
(Jeffcoat et al).
Adenomyosis results grossly in an enlarged and globus uterus 
because of the myometrial hypertrophy that regularly accompanies it 
(Emge LA et al 1962).
The diagnosis may be suspected on cut section in the presence of 
depressed small cystic lesion in obivious but illdefined bulging zone 
of muscle hypertrophy (Ackerman et al 2004). The cause of 
endometrial and muscle growth is the estrogenic hormone of the 
ovary lend support to the belief that adenomyosis will be found to be 
seen to an endocrine dysfunction of the ovary (Cullen et al 1908, 
Marcus et al 1961)
LEIOMYOMA UTERUS AND ASSOCIATED CONDITIONS
LEIOMYOMA  UTERUS  CORRELATION  WITH  CYCLICAL 
CHANGES ENDOMENTRIUM
In the presence of leiomyoma, the endometrium undergoes primarily 
histophysiological and age-related changes (Zheleznov BI et al 1990)
Endometrial structures were normal in 54% of 178 myoma patient 
and phases of incomplete secretion were recorded in 14.6% (Zentral 
BI et al gynakol 1982, Landecho wshij JD et al 1982).
LEIOMYOMA AND ENDOMETRIAL THICKNESS
L.Deligdish et al study of endometrium with myoma, atrophic 
endometrium were the most constant morphological changes in the 
presence of uterine mainly submucous myoma (83%). Atrophy may 
result not only from mechanical pressure but also from 
postmenpausal hormonal insufficiency (J.clin path). The myometrial 
tumor is large the over lying endometrium may be thinned out (CH- 
Bukley et al 1989).
LEIOMYOMA AND ENDOMETRIAL HYPERPLASIA
According to Block et al (1961) reported that the association between 
uterine myoma and endometrial hyperplasia varied between 6% and 
80%. Goranjon, Ganotti et al (1961) found high oestrogen levels in 
woman with uterine fibroid and believed that the endometrium 
played role in the synthesis of oestrogens.
Hyperplasia is the most common change in the endometrium 
associated with fibroid uterus. Mechanical cause may play a role 
(Acta Obs. Gynae. 1963).
Teleman S et al (2003) study of 390 specimens of hysrectomy, 316 
cases presented different degrees of endometrial hyperplasias 
associated with leiomyoma. Leiomyoma and endometrial hyperplasia 
develop is a hormonal context. The most frequent type is simple 
hyperplasia suggesting a rare progression to highest grades and a 
possible protective role of leiomyoma as target tissue which capture 
estrogens.
The authors analysed 600 patients with uterine leiomyoma from 
hysterectomy performed for condition when leiomyoma were also 
studied for control purpose. Major conditions found include 
endomentrial hyperplasia. (Szajnbok et al 1990)
Biopsy  specimens  of  the  endometricm  obtained  from  the  154 
cases diagnosed showed that functional uterine bleeding has the higher 
incidence followed by myoma of the uterus. (Tsuka et al 1983)
Endometrium in association with myoma show little or no departure 
from the normal and the histologic sequence of cyclic change may 
occur just as it does in the ovulatory cycle of non-myomatous 
patient. On the other hand, in considerable proportion of case he 
finds an association of non ovulatory type of cycle with myoma with 
frequently a hyperplasia of the endometrium of more or less marked 
degree (Novack et al).
Hyperplasia of the endometrium was recordable primary from patient 
with menopausal  ovarian dysfunction  in pt. with uterine myoma 
(Lond et al, 1982).
In 103 out of 786 patient with hyperplasia, myomatous changes were 
noted. This finding correlated with hyperestrogenism, which is 
usually present in both disorders  (Todorovic N et al, 2002). 
LEIOMYOMA AND ADENOMYOSIS
In Ben Aissia N et al study of analysis of 35 cases of adenomyosis, 
uterine fibroma is associated in 62% of cases (tunis med.2001)
Adenomyosis is more frequently associated with leiomyoma but 
essential adenomyosis was diagnosed most constantly when uterine 
enlargement was noted during menstrul period. (Thomas TS Jr et al 
1989).
Adenomyosis was noted in 16% of 2,616 consequtive hystrectomy 
specimens examined during 7 year period. Multi parous women 
between the ages 30 and 50 years were most commonly affected. 
Abnormal uterine bleeding was the common symptom. 
Myohyperplasia, leiomyoma  were usual associated lesion. It is seen 
equally in women of Africa, India and mixed races in the West 
Indian population (Raju GC et al 1988)
LEIOMYOMA AND ENDOMETRIAL CARCINOMA
There are a few reported cases of endometrial carcinoma in 
association with leiomyoma. The percentage varies 0.2 to 16.2% 
(Dupantier N et al 2003, Tatamizawa S et al 1999, Studzinki Z et al 
2000, Cabrerce J et al 1994, Studzinski et al 1998). According to 
Zhonghua L et al 1990, there is no association of endometrial carcinoma 
and leiomyo
               MATERIALS AND METHODS
SOURCE OF DATA
A total of 1680 hysterectomy specimens were received for various 
diseases in the department of pathology, Stanley Medical College 
from obstetrics and gynaecology department, RSRM, Chennai, from 
August 2003 to February 2006. Among the hysterectomy specimen 
received during the study period, only those specimens with fibroid 
were taken up for the study.
METHOD OF COLLECTION OF DATA
The material includes 375 cases of hysterectomy specimens along 
with  fibroid  with  unilateral  or  bilateral  salphingoophorectomy.  The 
clinical details including LMP, LCB, cycle periodicity of the patients 
were  taken  from  the  records  in  medical  records  department.10% 
buffered  formalin  has  been  used  for  fixation  of  specimens.  The 
following  parameters  size  of  the  uterus,  ovary,  tubes,  thickness  of 
endometrium, number, site, size, shape and consistency of fibroids were 
noted.
Multiple  bits  of  full  thickness  endometrium along with bits  of 
fibroid of 2 to 3 cms were taken. A total of 465 hysterectomy specimens 
with fibroid were taken, among them 90 specimens showed complete 
obliteration of endometrium, so these specimens were not included in 
the study. The tissue slices were processed in various grades of alcohol 
and xylol.  Paraffin  blocks were prepared subsequently.  Multiple  thin 
sections of 5 microns were cut from the paraffin blocks and stained with 
routine method (Haematoxylin and eosin).
The endometrial changes of endometrium in relation to LMP. The 
results were tabulated 
Photographs of the appropriate specimens and photomicrographs 
of the slides are furnished.
OBSERVATIONS AND RESULTS
INCIDENCE OF UTERINE LEIOMYOMA
1680 hysterectomy specimens were received during the period of 
August 2003 to February 2006 out of which 465 showed leiomyomas. 
Incidence of leiomyoma among the hysterectomy specimen was 
27.67%.  (Table 1, Diagram 1)
AGE INCIDENCE OF LEIOMYOMA
The age group were divided as 1 to 9, 10 to 19, 20 to 29, 30 to 39, 40 
to 49, 50 to 59, 60 to 69 and above 69 years. Of these the age group 
30 to 49 formed the largest. The mean age was 40 years. The 
youngest and oldest age incidence of leiomyoma were 30 and 62 
respectively.  
(Table 2, Diagram 2 & 3)
DISTRIBUTION ACCORDING TO SITE
Of 375 cases, 24% of fibroids were submucous in location. 
Intramural and subserous were 47.2% and 4.87% respectively. Both 
submucous and intramural locations of leiomyomas were 13.82%. 
Submucus and intramural were 4%. Submucous+subserous were 4.87%. 
The leiomyomas located in all three locations were only 1.6%. (Table 3, 
Diagram 4)
NUMBER OF FIBROID
Table 4, Diagram 5 show distribution of leiomyomas according to 
number. 
216 had a single fibroid (57.6%) and 60 had two fibroids (16%)
Those with multiple fibroids were 99 (26.4%)
In this study most of the specimens had single fibroid.
CHANGES IN ENDOMETRIUM
Out of 375 specimens, 93 showed simple hyperplasia with an 
incidence of 24.8%, 0.8% showed complex hyperplasia, 0.8% were 
showed senile cystic hyperplasia. Irregular proliferative phase 
presented in 5.6%. The incidence of proliferative phase was 45.60%. 
Early secretory phase was 2.4%, late secretory phase was 13.6%. 
Atrophic endometrium was seen in 6.4% cases. (Table 5, Diagram 6)
CHANGES OF ENDOMETRIUM IN SUMUCOUS LEIOMYOMA
Out of 90 cases of submucous fibroid, the incidence of simple 
hyperplasia was 26.66%, proliferative phase was 40%, simple cystic 
hyperplasia was 3.33%. Irregular proliferative showed in 10% of 
cases. Early secretory phase, late secretory phase, atrophic 
endometrium were 3.33%, 13.33% 3.33% respectively.
IN THE CASES OF INTRA MURAL LEIOMYOMA
Out of 177 cases of intramural fibroid, the incidence of simple 
hyperplasia was 20.33%. Complex hyperplasia was 1.69%. 1.69 cases 
showed irregular proliferation. The incidence of proliferative phase was 
52.54% and early secretory phase, late secretory phase, atrophic 
endometrium were 1.69%, 11.86%, 10.16% respectively.
IN THE CASES OF SUBSEROUS FIBROID
Out of 18 cases of subserous fibroid, the incidence of proliferative 
phase and atrophic endometrium were 83.33% and 16.66% respectively. 
The endometrial changes associated with fibroid on the basis of 
location were depicted in table 6. 
AGE RELATED CHANGES IN ENDOMETRIUM WITH 
FIBROID
No cases were seen below 30 years
Between 30 to 39 years
168 cases were belonged to this age group. 23.2% showed simple 
hyperplasia. 53.6% of cases showed proliferative phase. Late secretory 
phase showed 12.5% of cases.  5.3% showed irregular proliferation. 
3.6% showed early secretory phase. Atrophic endometrium showed only 
1.8%.
Between 40 to 49 years
174 cases were in this age group.
The incidence of simple hyperplasia in this age group was 27.5%. 
1.7% showed complex hyperplasia. 6.9% showed irregular proliferation. 
1.7% showed early secretory phase. Proliferative phase, Late secretory 
phase and atrophic endometrium were 43.10%, 15.5%, 3.4% 
respectively.  
Between 50 to  59 years
27 cases were reported in this age group. 22.2% showed simple 
hyperplasia. 22.2% showed proliferative phase. 11.1% showed senile 
cystic hyperplasia. 33.3% showed atrophic endometrium. 11.1% 
showed senile cystic hyperplasia.
Between 60 to  69 years
There were only 6 cases seen in this category, showed atrophic 
endometrium (100%).
Above 69 years
No cases were seen in this age group. (Table 7)
ENDOMETRIAL CHAGES WITH FIBROID RELATED WITH 
LMP
In this study LMP in days were divided into 3 groups as 7 to 15, 
16 to 30 and more than 30. (Table 8)
7 to 15 days
Only 15 cases belonged to this group
6 cases showed simple hyperplasia of incidence 40%
6 cases showed proliferative phase of incidence 40%
Only 3 cases showed Irregular proliferation (20%)
16 to 30 days
No. of cases belonged to this group was 171
42 cases showed simple hyperplasia (24.6%)
  9 cases showed irregular proliferation (5.2%)
72 cases showed proliferative phase of incidence (42.1%)
39 cases showed late secretory phase (22.8%)
  9 cases showed early secretory phase (5.3%)
Above 30 days
Total no. of cases in this group were 189
93 cases showed proliferative phase (49.2%)
45 cases showed simple hyperplasia (23.8%)
24 cases showed atrophic endometrium (12.6%)
  3 cases showed complex hyperplasia (1.6%)
  3 cases showed senile cystic hyperplasia (1.6%)
  9 cases showed irregular proliferation (4.8%)
12 cases showed late secretory phase (6.3%)
ADENOMYOSIS ASSOCIATED FIBROID UTERUS
Of total 375 cases of fibroid study 108 cases showed adenomyosis 
accounting for 28.8%. (Table 9, Diagram 7)
Age Incidence
Table 10 and diagram 8 showed age incidence of adenomyosis 
associated with leiomyoma. No cases were found below 30 years. 
33 cases out of 108 cases were in age group between 30 to 39 years 
(30.5%)
66 cases out of 108 cases were in age group between 40 to 49 years 
(61.1%)
9 cases out of 108 cases were in age group between 50 to 59 years 
(8.3%) 
There were no cases seen above 59 years. (0.0%)
Maximum  number  of  adenomyosis  cases  occurred  between  the  age 
group 30 to 49 years. The incidence was 91.66%.
Based On LMP In Days
 6 cases were in 7 to 15 days of LMP (5.55%) 
48 cases were in 16 to 30 days (44%)
54 cases were in showed adenomyosis of LMP more than 30 days 
(50%) (Table 11, Diagram 9).
CHANGES IN ENDOMETRIAL THICKNESS
The normal endometrial thickness was 0.3 to 0.5cm . The reduced 
thickness was of range between 0.1 to 0.2cm. These reduced thickness 
were seen in endometrium of all submucous fibroids, large intramural 
fibroid and fibroid cases of all post menopausal women. 
No  association  of  leiomyoma  with  endometrial  carcinoma  was 
seen.
                                        TABLE 1
INCIDENCE OF LEIOMYOMA
S.No. Disease
No. of Hysterectormy 
specimens Percentage
1 Fibroid 465 27.67%
2 DUB 270 16.07%
3 Ovarian Neoplasm 198 11.78%
4 Prolapse Uterus 630 37.5%
5 Cervical Dysplasia 48 2.8%
6 PID 36 2.14%
7 Adenomyosis 33 2.13%
Total 1680 100%
TABLE 2
AGE INCIDENCE OF LEIOMYOMA
S.No. Age in years No. of cases Percentage
1 1-9 - -
2 10-19 - -
3 20-29 - -
4 30-39 168 44.8%
5 40-49 174 46.4%
6 50-59 27 7.2%
7 60-69 6 1.6%
7 70 & above - -
Total 375 100
TABLE 3
LEIOMYOMA BASED ON LOCATION IN UTERUS
S.No. Location Number Percentage
1 SubMucous 90 24%
2 Intra Mural 177 47.20%
3 Sub Serous 18 4.87%
4 Sub Mucous (+) Intra Mural 51 13.82%
5 Sub Serous (+) Intra Mural 15 4%
6 Sub Mucous + Sub Serous 18 4.87%
7 Sub Mucous + Sub Serous + Intra Mural 6 1.60%
Total 375 100%
TABLE 4
LEIOMYOMA UTERUS BASED ON NUMBER
S.No. Number Percentage
1. Single 216 57.6%
2. Two 60 16%
3. Multiple 99 26.4%
Total 375 100%
TABLE 5
ENDOMETRIAL CHANGES ASSOCIATED WITH FIBROID 
UTERUS
S.No. Endometrial Change Number Percentage
1 Simple Hyperplasia 93 24.8%
2 Complex Hyperplasia 3 0.8%
3 Senile Cystic Hyperplasia 3 0.8%
4 Irregular Proliferation 21 5.6%
5 Proliferative Phase 171 45.6%
6 Early Secretory Phase 9 2.4%
7 Late Secretory Phase 51 13.6%
8 Atrophic Endometrium 24 6.4%
Total 375 100%
TABLE 6
ENDOMETRIAL CHANGES ASSOCIATED WITH FIBROID 
UTERUS 
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1 1-9 - - - - - - - -
2 10-19 - - - - - - - -


































































































































































































OCCURRENCE OF ADENOMYOSIS ASSOCIATED WITH 
FIBROID
UTERUS AGE RELATED
S.No. Age in years Adenomyosis Percentage
1 1-9 - -
2 10-19 - -
3 20-29 - -
4 30-39 33 30.55%
5 40-49 66 61.11%
6 50-59 9 8.33%
60-69 - -
7 70 & above - -
Total 108 100%
                                             TABLE 11
ADENOMYOSIS ASSOCIATED WITH FIBROID UTERUS 
BASED ON LMP
S.NO. LMP in days Adenomyosis Percentage
1 7-15 6 5.55%
2 16-30 48 44.44%
3 >30 54 50%
Total 108 100%
                                            DISCUSSION
Leiomyoma  of  the  uterus  is  an  extremely  common  neoplasm. 
Many  of  these  tumours  are  small  and  so  undetected  and  are  often 
incidental  findings.  In  the  current  study  over  a  period  of  2.5  years 
(August  2003  to  February  2006),  1680  hysterectomy  specimen  were 
received  of  which  465  revealed  leiomyomas  with  an  incidence  of 
27.67%.  Ackerman  et  al  did  a  meticulous  study  of  100  consecutive 
hysterectomy  specimen  of  which  77  revealed  leiomyomas.  The  low 
incidence  in  our  study  can  be  partly  explained  by  conservative 
management of leiomyoma by gynaecologists. 
Although Ackerman et al reported 84% of leiomyomas as 
multicentric, current study showed an increased incidence of single 
fibroids. Of 375 leiomyomas 52% were single and 20%, 28% were 
double and multiple respectively. This difference needs to be further 
evaluated.
Leiomyoma occurs chiefly in women during active mid 
reproductive years. They are present in 20 to 30% of women over 30 
years of age, rising to more than 40% in those over 40 years old 
(Malcom.C, Anderson et al). Premenopausal patients showed an average 
number of myoma almost three times higher than post menopausual 
women (Cabrera et al 1994). In current study of 375 cases, 342 cases 
were in the age group between 30 to 49 years (91.2%). The mean age 
was 40 years. In this study most of the cases occurred in premenopausal 
women. Only 3.2% of cases were seen in post menopausual women age 
group. This could be explained of the theory of enhanced estrogen 
stimulation causing uterine fibroids is concerned.  (Muram et al).
Within the uterus the leiomyoma can be intramural, subserous and 
submucous.  Shaw et al noted these were 75%, 10% and 15% in their 
study group.
In this study of 375 cases 47.2% of cases showed intra mural 
fibroids. 24% showed in submucous region only 4.87% were 
subserous location. Both in submucous and intramural region were 
13.82%. This finding is in accordance with the reference cited. 
ENDOMETRIAL CHANGES
In  the  current  study  of  375 cases,  45.6% showed proliferative 
phase  and  6.4%  showed  atrophic  endometrium.  The  early  and  late 
secretory  phase  were  seen  in  2.4%  and  13.6%  respectively.  5.6% 
showed irregular proliferation. These features were in accordance with 
number of literature studied. Granjone Yanotti and Cedavd (1961) found 
high estrogen level in women with uterine fibroids and believed that 
endometrium played a role in synthesis of estrogen. According to CH 
Buckley, H Fox et al, however the changes are insufficient to warrant a 
diagnosis of hyperplasia but are recognizable as those of a prolonged 
proliferative phase in some patients. Mitotic activity continues beyond 
the 14th day of the cycle.
According to Zhleznov BI et al., 1990, in the cases of leiomyoma, 
the endometrium undergoes primarily histopathological and age related 
changes According to Land echowskij JD et al., 1982,. endometrial 
structures were normal in 54% of 178 myoma patient and phases of 
incomplete secretion were recorded from 14.6% 
If the myometrial tumour is large, the overlying endometrium may be 
thinned out (CH Bukley et al 1989). The atrophic endometrium were 
the most constant morphological changes in the presence of 
leiomyoma mainly of submucous type (83%). Atrophy is not only 
due to mechanical pressure but also from the post menopusual 
hormonal insufficiency (L.Deligdish et al Study- J. clinic Path 1970). 
In accordance with this study, the current study showed thinned out 
endometrium of 0.1 to 0.2cm in all the 90 submucous fibroid cases 
and in 57 out of 177 cases of intra mural fibroid and 24 cases of post 
menopausual women. 
Bolck et al 1961 reported endometrial hyperplasia varied between 
6% and 80%. Hyperplasia is the most common changes in the 
endometrium with fibroid uterus (Acta Ob.Gynec. 1963). Out of 390 
hysterectomy specimen, 316 cases presented with different degrees of 
endometrial hyperplasia with leiomyoma. Leiomyoma and endometrial 
hyperplasia develop in hormonl context. The most frequent type is 
simple hyperplasia, suggesting  a rare progression to highest grades and 
a possible protective role of leiomyoma as a target tissue which capture 
estrogen (Teleman S et al, 2003). Lattinen (1964) reported that 
hyperplasia was the most common change in the endometrium 
belonging to myoma uterus (J clin path 1970). In accordance with these 
studies the current study showed 93 cases of simple hyperplasia out of 
375 cases.  The incidence was 24.8%.  Complex hyperplasia, senile 
cystic hyperplasia of incidence of 0.8% of each.  These features are due 
to protective role of uterine myoma.  
Although Deligdish et al study of submucous myoma of 30 cases in 
the age group between 31 to 52 years showed glandular atrophy over 
myoma was the constant finding and margin of myoma showed 
frequently of hyperplastic glands, in the current study out of 90 cases 
of submucous leiomyoma the incidence of simple hyperplasia was 
26.66%.  40% showed proliferative phase and only 3.33% showed 
atrophic endometrium.  This could be attributed to the young age of 
the patient involved (i.e. active reproductive age group).  (Malcom. 
C, Anbderson et al).
In the presence of leiomyoma the endometrium undergoes primarily 
histophysiological and age related changes (Zhelezenov Bi et al 
1990).  Hyperplasia of the endometrium was recordable primarily 
from the patient with menopausal ovarian disfunction (Zentrabl 
gynekol 1982).  In the current study most of the cases were between 
30 to 49 years.  Of this group simple hyperplasia was seen in 25.4%. 
48.2% showed proliferative phase.  14% showed late secretory 
phase.  Only 9 cases belonged to age more than 55 years.  Of these 6 
cases showed atrophic endometrium and 3 cases showed senile cystic 
hyperplasia.
Goranjon et al 1961 found high estrogen levels in women with 
uterine fibroid and believed that  the endometrium played role  in  the 
synthesis  of  estrogens.   Novak and wood druff  (1962)  described the 
association between myoma and the non-ovulatory type of cycle with 
hyperplasia of endometrium.  In some patient, however the changes are 
insufficient to warrant a diagnosis of hyperplasia but are recognizable as 
those of  a prolonged proliferative phase.   Mitotic activity continuous 
beyond the 14th day of cycle (CH Bukley et al). In this study out of 375 
cases 171 cases had LMP of 16 to 30 days and 189 cases more than 30 
days of LMP.  165 cases out of 375 cases showed persistent proliferative 
phase with LMP more than 15 days.  87 cases out of 375 cases showed 
Hyperplasia had LMP of more than 15 days. This showed unopposed 
estrogenic  action (Hyper  estrogenic  stage).  24 cases  showed atrophic 
endometrium, were postmenopausal women.
 
Adenomyosis in leiomyoma was associated feature seen in the study. 
108 out of 375 leiomyomas was associated with adenomyosis 
forming 23.8%. Ben Aissia N et al (2001) had reported 62% and 
Raju GC et al (1980) reported 16% and Thomas JS et al (1989) had 
noted more frequent association. Raju GC et al study 1980, noted 
that association of adenomyosis in leiomyoma was most commonly 
seen in multiparous women between the ages 30 and 50 years. The 
present study also, 91.66% of leiomyoma in the age group of 30 to 
49 were seen to be associated with adenomyosis.
No endometrial  and uterine malignancies  were reported in this 
study. Site wise distribution of leiomyoma show persistent proliferative 
feature or simple hyperplasia, indicates hyperestrogenic status. But there 
were  no  abnormal  incidence  of  more  worrisome  lesions  like 
complex/atypical hyperplasia.
There are a few reported cases of endometrial carcinoma in association 
with leiomyoma. The percentage varies 0.2 to 16.2% (Dupantier N et al 
2003, Tatamizawa S et al 1999, Studzinki Z et al 2000, Cabrerce J et al 
1994, Studzinski et al 1998). According to Zhonghua L et al 1990, there 
is no association of endometrial carcinoma and leiomyoma. The present 
study also reveal there is no association of leiomyoma and endometrial 
carcinoma. This points to the fact, that there could be protective role of 
leiomyoma on endometrium hypothesized by Teleman S et al 2003. 
SUMMARY AND CONCLUSION
During the study period between August 2003 to February 2006, 
375  hysterectomy  specimens  with  leiomyoma  were  taken  up  for 
studying endometrial changes 
1. The incidence of leiomyoma was 27.67%
2. Most  of  leiomyoma  were  seen  in  premenopausal  women,  of  age 
group between 30 to 49 years with an incidence of 91.2%
3. Only 3.2% of were seen in postmenopausal age group.
4. This study showed a higher incidence of unicentric fibroid with an 
incidence of 52%
5. Most  of  the  fibroids  were  occurred  in  intramural  location  of  an 
incidence 47.2% followed by submucous fibroid with an incidence of 
24%
6. The  endometrium  were  thinned  out  (0.1  to  0.2cm)  in  all  the  90 
submucous fibroid, 57 intramural fibroid and 24 of postmenopausal 
women
7. 45.6%  showed  proliferative  phase.  6.4%  showed  atrophic 
endometrium.
8. 93 showed simple hyperplasia that is 24.8%. Complex hyperplasia 
and senile cystic hyperplasia were 0.8% each.
9. Of 90 submucous myoma, simple hyperplasia was seen in 26.66%. 
40%  showed  proliferative  phase  and  only  3.3%  showed  atrophic 
endometrium.
10.Most of the cases were between 30 to 49 years (91.2%). In this age 
group, simple hyperplasia seen in 23.4%. 44.4% showed proliferative 
phase. 12.8% showed late secretory phase.
11.Above 55 years age group only 9 cases were reported. Of these 6 
showed  atrophic  endometrium  and  3  showed  senile  cystic 
hyperplasia.
12.In this study, 171 cases had LMP of 16 to 30 days and 189 had more 
than 30 days of LMP.
13.165 cases showed persistent proliferative phase with LMP more than 
15 days.
14.87 cases showed endometrial hyperplasia with LMP of more than 15 
days.
15.Adenomyosis  was associated  with 108 cases with an incidence of 
23.8%.
16.Maximum  mumbers  of  Adenomyosis  was  seen  between  the  age 
group 30 to 49 years. The incidence of adenomyosis in this age group 
was 91.66%.
The  incidence  of  leiomyoma  is  almost  equal  to  other  data 
available in the world literature. 
Endometrial changes noted also correlated with findings of other 
authors.
Many authors had worked on the endometrial changes in fibroid 
uterus.  A  comparison  with  those  studies  revealed  then  the  current 
observations were corrobarative except for few variations.
A striking observation was the association of adenomyosis  and 
fibroid,  23.8% uterine  leiomyoma  was  associated  with  adenomyosis, 
which  substantiates  the  hypothesis  of  hormonal  dependency  of  this 
tumours.
Persistent  proliferative phase and simple hyperplasia  were seen 
beyond 15 days of LMP. This constituted 252 out of 375 cases, which 
means  67%  showed  hyperestrogenic  status,  which  also  explains  the 
various  menstural  disturbance  the  patient  present  with.  Reproductive 
failure may also be explained by these changes.
Though L Deligish and M Loe observed atrophic endometrium in 
83% of submucous myoma, which is only a pressure change, here there 
were  significant  number  of  cases  showed  proliferative  phase,  which 
could only be explained by the lower age group affected.
No association  of  leiomyoma  with  endometrial  carcinoma  was 
seen.  There  were  very  few  cases  reported  in  the  literature  which 
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LEIOMYOMA BASED ON LOCATION
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a) Frequency of micturition:
b) Difficulty in micturition:
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d) Low back ache:
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a) Lower abdominal pain:
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